Therefore, inhibition of SGLT2 can increase glucose excretion and decrease glucose reabsorption in renal tubules, thereby reducing the blood glucose level and improving insulin resistance in T2DM patients [5]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.